9KY2 | pdb_00009ky2

Structure of beta-arrestin2 in complex with mouse C5aR1pp


Experimental Data Snapshot

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.78 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 

wwPDB Validation   3D Report Full Report


This is version 1.0 of the entry. See complete history


Literature

Molecular fingerprints of a convergent mechanism orchestrating diverse ligand recognition and species-specific pharmacology at the complement anaphylatoxin receptors.

Mishra, S.Yadav, M.K.Dalal, A.Ganguly, M.Yadav, R.Sawada, K.Tiwari, D.Roy, N.Banerjee, N.Fung, J.N.Marallag, J.Cui, C.S.Li, X.X.Lee, J.D.Dsouza, C.A.Saha, S.Sarma, P.Rawat, G.Zhu, H.Khant, H.A.Clark, R.J.Sano, F.K.Banerjee, R.Woodruff, T.M.Nureki, O.Gati, C.Shukla, A.K.

(2025) bioRxiv 

  • DOI: https://doi.org/10.1101/2025.05.26.656101
  • Primary Citation of Related Structures:  
    9KUG, 9KUT, 9KV6, 9KV8, 9KVP, 9KWG, 9KWX, 9KX6, 9KXS, 9KY2, 9KYU, 9KZ2, 9KZ8, 9KZK, 9L0H, 9UMJ, 9UMR, 9UMX

  • PubMed Abstract: 

    Complement anaphylatoxin receptors (C3aR and C5aR1) are prototypical G protein-coupled receptors (GPCRs) playing crucial physiological roles in innate immunity by combating pathogenic infections and orchestrating inflammatory responses. They continue to be important therapeutic targets for multiple disorders including autoimmune diseases, acute and chronic inflammation, and allergy-related conditions. Recent structural coverage has provided important insights into their activation and signaling, however, confounding observations in the literature related to ligand efficacy and functional responses, especially in different model systems, present a major challenge for drug discovery efforts. Here, we systematically and comprehensively profile a broad set of natural and synthetic ligands at C3aR and C5aR1 and discover a previously unanticipated level of functional specialization in terms of species-specific pharmacology and receptor activation. Taking a lead from this, we determine seventeen cryo-EM structures of different ligand-receptor-G-protein complexes and uncover distinct orientation of agonists between the human and mouse receptors despite an overlapping positioning in the orthosteric binding pocket. Combined with extensive mutagenesis and functional assays, these structural snapshots allow us to decode and validate a convergent molecular mechanism involving a "Five-Point-Switch" in these receptors that orchestrates the recognition and efficacy of diverse agonists. We also identify species-specific differences at the level of phosphorylation patterns encoded in the carboxyl-terminus of these receptors and directly visualize their impact on βarr binding and activation using cryo-EM structures. Interestingly, we observe that βarrs engage with the mouse C5aR1 using a variation of previously discovered P-X-P-P phosphorylation motif via a "Sliding-Mechanism" and also exhibit distinct oligomeric state for the human vs. mouse receptors. Taken together, this study elucidates functional specialization at the complement anaphylatoxin receptors and underlying molecular mechanisms, offering a previously lacking framework with direct and immediate implications for the development of novel therapeutics.


  • Organizational Affiliation
    • Department of Biological Sciences and Bioengineering, Indian Institute of Technology, Kanpur 208016, India.

Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Beta-arrestin-2
A, F
420Bos taurusMutation(s): 11 
Gene Names: ARRB2
UniProt
Find proteins for P32120 (Bos taurus)
Explore P32120 
Go to UniProtKB:  P32120
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP32120
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 2
MoleculeChains Sequence LengthOrganismDetailsImage
Fab30 Heavy Chain
B, D
237Mus musculusMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 3
MoleculeChains Sequence LengthOrganismDetailsImage
Fab30 Light Chain
C, E
215Mus musculusMutation(s): 0 
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
Sequence Annotations
Expand
  • Reference Sequence

Find similar proteins by:  Sequence   |   3D Structure  

Entity ID: 4
MoleculeChains Sequence LengthOrganismDetailsImage
C5a anaphylatoxin chemotactic receptor 1G [auth V],
H [auth U]
23Mus musculusMutation(s): 0 
UniProt
Find proteins for P30993 (Mus musculus)
Explore P30993 
Go to UniProtKB:  P30993
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP30993
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Modified Residues  2 Unique
IDChains TypeFormula2D DiagramParent
SEP
Query on SEP
G [auth V],
H [auth U]
L-PEPTIDE LINKINGC3 H8 N O6 PSER
TPO
Query on TPO
G [auth V],
H [auth U]
L-PEPTIDE LINKINGC4 H10 N O6 PTHR
Experimental Data & Validation

Experimental Data

  • Method: ELECTRON MICROSCOPY
  • Resolution: 2.78 Å
  • Aggregation State: PARTICLE 
  • Reconstruction Method: SINGLE PARTICLE 
EM Software:
TaskSoftware PackageVersion
MODEL REFINEMENTPHENIX
RECONSTRUCTIONcryoSPARC4.6.2

Structure Validation

View Full Validation Report



Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Science and Engineering Research Board (SERB)IndiaIPA/2020/000405
Wellcome TrustUnited KingdomIA/S/20/1/504916
Science and Engineering Research Board (SERB)IndiaCRG/2022/002646

Revision History  (Full details and data files)

  • Version 1.0: 2025-11-26
    Type: Initial release